Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids

Details for Australian Patent Application No. 2005210086 (hide)

Owner MEDA Pharma GmbH & Co. KG

Inventors Maus, Joachim; Szelenyi, Istvan; Hoffmann, Torsten; Weingart, Mario; Petzold, Ursula

Agent Spruson & Ferguson

Pub. Number AU-A-2005210086

PCT Pub. Number WO2005/074983

Priority 60/541,950 06.02.04 US

Filing date 24 January 2005

Wipo publication date 18 August 2005

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

3 August 2006 PCT application entered the National Phase

  PCT publication WO2005/074983 Priority application(s): WO2005/074983

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210090-Synthesis of noble metal sulphilde catalysts in a sulphide ion-free aqueous environment

2005210085-The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD